# Arterial Disease Multifactorial Intervention Trial (ADMIT)

> **NCT00000539** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Arterial Occlusive Diseases
- Cardiovascular Diseases
- Heart Diseases
- Vascular Diseases
- Diabetes Mellitus

## Interventions

- **DRUG:** niacin
- **DRUG:** pravastatin
- **DRUG:** beta-carotene
- **DRUG:** vitamin E
- **BEHAVIORAL:** dietary supplements
- **DRUG:** vitamin C
- **DRUG:** warfarin

## Key facts

- **NCT ID:** NCT00000539
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1992-09
- **Primary completion:** —
- **Final completion:** 1999-03
- **Target enrollment:** — (—)
- **Last updated:** 2016-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000539, "Arterial Disease Multifactorial Intervention Trial (ADMIT)". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT00000539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*